Systematic Review
Accepted on 11 Feb 2026
The impact of bright light therapy on non-motor symptoms in patients with Parkinson's disease: a systematic review and Meta-analysis
in Dementia and Neurodegenerative Diseases
Frontiers in Neurology
Type at least 3 characters
777 articles
articles
Original Research
Published on 10 Feb 2026
Serum cystatin C and cognitive function in midlife: results from the Hanzhong Adolescent Hypertension Study
in Dementia and Neurodegenerative Diseases
Frontiers in Neurology
doi 10.3389/fneur.2026.1739512
- 345 views
Clinical Trial
Accepted on 09 Feb 2026
Six-month randomized, double-blind trial of transcranial direct current stimulation in mild Alzheimer's dementia: domain-specific cognitive and neuropsychiatric signals
in Dementia and Neurodegenerative Diseases
Frontiers in Neurology
- 114 views
Systematic Review
Published on 06 Feb 2026
Expression of matrix metalloproteinases in cerebral amyloid angiopathy-a systematic review
in Dementia and Neurodegenerative Diseases
Frontiers in Neurology
doi 10.3389/fneur.2026.1753708
- 560 views
Systematic Review
Published on 05 Feb 2026
Association of Alzheimer’s disease progression with YKL40 levels in peripheral blood and cerebrospinal fluid: a systematic review and meta-analysis
in Dementia and Neurodegenerative Diseases
Frontiers in Neurology
doi 10.3389/fneur.2026.1768353
- 493 views
Review
Accepted on 04 Feb 2026
Role of Prefrontal Cortex in Freezing of Gait in Parkinson's Disease: Mechanisms and Neuroimaging Evidence
in Dementia and Neurodegenerative Diseases
Frontiers in Neurology
- 169 views
Systematic Review
Accepted on 03 Feb 2026
Insulin-like Growth Factor 1 Associated Research in Alzheimer's Disease: An Exploratory Trends Analysis
in Dementia and Neurodegenerative Diseases
Frontiers in Neurology
Review
Accepted on 03 Feb 2026
Metabolic Dysfunction and Mitochondrial Failure in Alzheimer's Disease: Integrating Pathophysiology, Clinical Evidence and Emerging Interventions
in Dementia and Neurodegenerative Diseases
Frontiers in Neurology
- 149 views
Original Research
Accepted on 02 Feb 2026
Antibody elution methods for multiplex immunofluorescence of Alzheimer's disease pathology in human postmortem brain tissue
in Dementia and Neurodegenerative Diseases
Frontiers in Neurology
- 118 views
Original Research
Published on 29 Jan 2026
Analysis of comorbid characteristics, molecular mechanisms between mild cognitive impairment and Alzheimer’s disease with interventions in a community-based population in Shanghai
in Dementia and Neurodegenerative Diseases
Frontiers in Neurology
doi 10.3389/fneur.2026.1765285
- 449 views
Original Research
Published on 26 Jan 2026
Cognitive and neurobehavioral phenotypes of post 9/11 veterans with epilepsy and mild traumatic brain injury
in Dementia and Neurodegenerative Diseases
Frontiers in Neurology
doi 10.3389/fneur.2025.1706223
- 679 views
Original Research
Published on 23 Jan 2026
Influencing factors of initiation and maintenance of multidomain interventions in patients with mild cognitive impairment: a qualitative study
in Dementia and Neurodegenerative Diseases
Frontiers in Neurology
doi 10.3389/fneur.2025.1734487
- 703 views
Study Protocol
Published on 23 Jan 2026
Heat therapy in individuals at risk for Alzheimer’s disease—methods for a randomized controlled trial
in Dementia and Neurodegenerative Diseases
Frontiers in Neurology
doi 10.3389/fneur.2026.1736108
- 787 views
Brief Research Report
Published on 21 Jan 2026
Swallowing characteristics in Down syndrome at an advanced age: a preclinical study in the Ts65Dn mouse model
in Dementia and Neurodegenerative Diseases
Frontiers in Neurology
doi 10.3389/fneur.2026.1703041
- 652 views
Original Research
Accepted on 20 Jan 2026
Associations of Modified Triglyceride-Glucose Indices With Risks of Dementia Subtypes and Brain Structure: A Prospective Cohort Study
in Dementia and Neurodegenerative Diseases
Frontiers in Neurology
- 266 views
Original Research
Published on 20 Jan 2026
The diagnostic pathway of Alzheimer's disease in real-world clinical practice in Spain: results from the Adelphi Dementia Disease Specific Programme™
in Dementia and Neurodegenerative Diseases
Frontiers in Neurology
doi 10.3389/fneur.2025.1702805
- 1,394 views
Review
Published on 14 Jan 2026
Dual role of exosomes in neurodegenerative diseases: a molecular bridge between neuroinflammation and transmission of pathological proteins
in Dementia and Neurodegenerative Diseases
Frontiers in Neurology
doi 10.3389/fneur.2025.1708655
- 1,874 views
Original Research
Accepted on 13 Jan 2026
Characteristics of brain computed tomography in dementia with cardiovascular disease and psychological and behavioral symptoms
in Dementia and Neurodegenerative Diseases
Frontiers in Neurology
- 189 views
Brief Research Report
Accepted on 13 Jan 2026
Quantitative evaluation of iron chelator effects on central motor and sensory tracts in superficial siderosis
in Dementia and Neurodegenerative Diseases
Frontiers in Neurology
- 167 views
Perspective
Accepted on 12 Jan 2026
Beyond the Triad: Incorporating Alzheimer's Disease and α-Synuclein Testing in the Evaluation of Idiopathic Normal Pressure Hydrocephalus
in Dementia and Neurodegenerative Diseases
Frontiers in Neurology
- 191 views
Original Research
Published on 12 Jan 2026
Thyroid function status and heterogeneity of efficacy of maintenance cognitive stimulation in late-life dementia: a stratified observational study of subclinical hypothyroidism/hyperthyroidism
in Dementia and Neurodegenerative Diseases
Frontiers in Neurology
doi 10.3389/fneur.2025.1710962
- 704 views
Original Research
Published on 06 Jan 2026
MALT1 in cerebrospinal fluid: a prognostic biomarker and potential therapeutic target in Alzheimer’s disease
in Dementia and Neurodegenerative Diseases
Frontiers in Neurology
doi 10.3389/fneur.2025.1732729
- 1,080 views
Original Research
Published on 05 Jan 2026
Neuropsychological and neuroimaging characteristics of patients with mild cognitive impairment and negative-amyloid deposition
in Dementia and Neurodegenerative Diseases
Frontiers in Neurology
doi 10.3389/fneur.2025.1658712
- 1,064 views
Original Research
Published on 19 Dec 2025
Canadian Creutzfeldt-Jakob disease incidence remained stable during the coronavirus disease (COVID-19) pandemic
in Dementia and Neurodegenerative Diseases
Frontiers in Neurology
doi 10.3389/fneur.2025.1729083
- 1,355 views